Stocks
Intellia Therapeutics (NTLA) ROE US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -25.8% | -38.4% | -45.8% | -59.5% | -61.5% | -61.5% | ||
| Changes by years, y/y, % | -2pp | -13pp | -7pp | -14pp | -2pp | +20.9% | |||
Intellia Therapeutics. ROE, %
Intellia Therapeutics. ROE, changes, pp
Intellia Therapeutics (NTLA) ROE US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| ROE, % | ? | -59.5% | -67.4% | -67.1% | -59.6% | -61.5% | -61.5% | |
| Changes by years, y/y, % | -14pp | -21pp | -15pp | -5pp | -2pp | |||
| Changes by quarters, q/q, % | -5pp | -8pp | +0pp | +8pp | -2pp | |||
